chevron_leftBack
As of 24 April 2025, China Isotope & Radiation Corp. has a market cap of $474.16M USD, ranking #12196 globally and #3913 in China. It ranks #1194 in the Healthcare sector, and #133 in the Medical Devices industry.
Key Stats
Market Cap
$474.16MUSD
3.68B HKD
Enterprise Value
$834.81MUSD
6.48B HKD
Revenue (TTM)
$1.04BUSD
8.06B HKD
EBITDA (TTM)
$176.32MUSD
1.37B HKD
Net Income (TTM)
$55.78MUSD
432.74M HKD
EBITDA Margin
17%
Profit Margin
5.4%
PE Ratio
8.5
Company Profile
Country (HQ)
Sector
Healthcare
Industry
Medical Devices
CEO
Junqi Zhang
open_in_new
Employees
3,367
Founded
1983
Website
circ.com.cn
open_in_new
warningChart data may be delayed
| 1d | 1w | 1m | 3m | 6m | 1y |
|---|---|---|---|---|---|
| -0.5% | 2.7% | -9.7% | 13% | 1.8% | 17% |
Markets
| Exchange | Ticker | Price |
|---|---|---|
|
1763
中国同辐股份有限公司 Ordinary Shares - Class H
ISIN: CNE1000031F4
Shares Out.:
Shares Outstanding:
79.969M1
Shares Float:
42.493M2
TV:
TradingView:
SA:
Stock Analysis:
YF:
Yahoo Finance:
GF:
Google Finance:
BA:
Barron's:
MS:
Morningstar:
|
11.50 HKD |
1Market cap is calculated using shares outstanding.
2Float shares are publicly tradable shares, excluding insider-held stock.
About China Isotope & Radiation Corp.
China Isotope & Radiation Corporation engages in the research and development, manufacture, and sale of diagnostic and therapeutic radiopharmaceuticals and radioactive source products for medical and industrial applications in China. It operates through five segments: Pharmaceuticals; Radioactive Source Products; Irradiation; Radiation Therapy Equipment and Related Services; and Other Businesses. The Pharmaceuticals segment engages in the research, development, manufacture, and sale of imaging diagnostic and therapeutic radiopharmaceuticals; urea breath test kits and analyzers; and in vitro immunoassay diagnostic reagents and kits. The Radioactive Source Products segment sells medical and industrial radioactive sources products and related technical services. The Irradiation segment offers irradiation services to manufacturers of medical devices, food, traditional Chinese medicine, and cosmetics for sterilization; and EPC services for the design, manufacturing, and installation of gamma ray irradiation facilities. The Radiation Therapy Equipment and Related Services segment sells radiation therapy equipment; and provides related maintenance services. The Other Businesses segment provides independent clinical laboratory services for nuclear technology industry applications and medical product applications; and sells radiation therapy equipment and other miscellaneous services. In addition, the company engages in the production and sale of bio-pharmaceuticals. The company was founded in 1983 and is headquartered in Beijing, China. China Isotope & Radiation Corporation is a subsidiary of China National Nuclear Corporation.
